Legal & General shares fall on lower solvency ratio

Core operating EPS 20.93p (up 9% YoY) missed estimates by 1.1%; core operating profit £1,623m (up 6% YoY) was 1.6% below consensus. Solvency II coverage ratio 210% was nine percentage points below analyst expectations, though operational surplus generation of £1,530m beat estimates by 4.6%. Legal & General announced a £1.2bn share buyback (largest ever) and total planned shareholder returns of £2.4bn; final dividend 15.67p (full-year 21.79p, +2%). Shares fell ~5.4% on the mixed results.

Analysis

Management’s tilt toward aggressive capital returns is a clear signal that internal returns on new underwriting and organic growth rank below buyback IRR thresholds; that re-prioritisation tightens available private-market dry powder and will push up acquisition multiples for minority stakes in infrastructure/private-credit managers over the next 6–12 months. Reduced free float from buybacks amplifies short-term volatility and increases sensitivity to flows — a single active manager reallocating a few percent of its UK equity sleeve can move the stock materially.

A solvency metric softer than models anticipated exposes the business to two linked second-order mechanisms: (1) margin-of-safety erosion that increases demand for reinsurance and longevity hedges, and (2) more active liability management to rebalance duration and credit risk. Both dynamics create upstream opportunity for reinsurers and derivatives desks while increasing hedging costs if hedging volumes surge concurrently across the sector.

Near-term catalysts are macro-driven: upcoming inflation prints and central-bank messaging will determine whether funding-credit spreads and curve levels reprice the insurer’s embedded economics. Over months, execution of the capital-return programme and private-asset monetisation will drive re-rating; over years, persistent pension de-risking and growth in private markets determine structural upside or downside.

Contrarian read: the market may be overstating a near-term earnings miss and understating the optionality from active capital allocation — if buybacks are executed opportunistically and paired with disciplined balance-sheet management, a multi-quarter re-rating is plausible. The key risks that reverse this view are adverse rate moves that widen hedging costs or regulatory intervention tightening capital rules.

Key Decisions for Investors

• Event-driven long LGEN (LSE: LGEN) — buy a 3–6 month call spread (e.g., buy 6-month ITM call, sell 6-month OTM call) sized for 2–3% portfolio exposure. Target 25–35% gross upside if buyback execution and macro prints align; hard stop at 12% of premium if CPI surprises to the downside.
• Pair trade — long LGEN / short PRU (Prudential plc) equal notional exposure for 6–12 months to capture idiosyncratic re-rating from capital returns while hedging sector risk. Take profit if spread narrows by 20–30% or if LGEN outperforms PRU by >15%; unwind if both move >15% on macro shock.
• Reinsurance hedge — buy RGA (RGA) or Swiss-re exposure (via liquid ETF or ADR) for 3–9 months to play increased demand for reinsurance/longevity hedges. Expect 15–25% upside if hedging demand materialises; cap risk with 10% stop-loss given sector cyclicality.
• Rotate into growth tech as macro hedge — buy SMCI (SMCI) 3–6 month calls (small position) to balance insurance exposure because positive growth re-rating in semiconductors can outperform during risk-on. Limit to 1–2% portfolio; target 40–60% upside on thematic squeeze, stop 50% of premium.